Indivior Pharmaceuticals Inc. Common Stock vs Rollins Inc. Common Stock — how do they compare? Indivior Pharmaceuticals Inc. Common Stock trades at $34.01 (market cap $4.18B), while Rollins Inc. Common Stock trades at $32.61 (market cap $15.47B). The key difference: Rollins Inc. Common Stock is far larger — about 3.7× Indivior Pharmaceuticals Inc. Common Stock's market cap, and Rollins Inc. Common Stock pays a 2.27% dividend while Indivior Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Indivior Pharmaceuticals Inc. Common Stock for 0 Days and Rollins Inc. Common Stock for 0 Days on average.
| INDV | ROL | |
|---|---|---|
Market Cap | $4.18B | $15.47B |
Volume | 1,819,746 | 6,712,154 |
Sector | Health | Industrials |
52-Week High | $41.83 | $65.60 |
52-Week Low | $24.09 | $29.69 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $4.47B | $16.48B |
Dividend Yield | — | 2.27% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.
Read more on INDV →Rollins Inc. provides pest control services to residential and commercial customers through its family of brands, including Orkin, across dozens of countries.
Read more on ROL →